OptimizeRx to Participate at Investor Conferences in November
Format: Virtual 1x1 meetings
Registration: Please contact your Stifel institutional sales representative.
OptimizeRx management is scheduled to participate in virtual one-on-one meetings with institutional investors and analysts at both conferences.
Management will discuss the company’s recently reported preliminary results for the third quarter of 2020. The company expects record revenue of more than
They will review how this growth is being driven organically by a combination of enterprise deals and tactical programs, as its life science customers increasingly see the value in transparent access to physicians and patients via the
To schedule a virtual one-on-one meeting with OptimizeRx, you may submit your request via the links provided upon your registration for the conferences. For any questions about the company, please contact Ron Both of CMA at (949) 432-7557 or submit your request here.
Stifel is a full-service investment firm with a distinguished history of providing securities brokerage, investment banking, trading, investment advisory, and related financial services to individual investors, institutions, corporations, and municipalities. Established in 1890 and headquartered in
For more information about Stifel, visit www.stifel.com.
Important Cautions Regarding Forward Looking Statements
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
Tel (248) 651-6568 (x807)
Media Relations Contact
Tel (754) 245-7070
Investor Relations Contact
Tel (949) 432-7557
Source: OptimizeRx Corporation